SoME ten years ago I reported a series of 49 cases of cystic fibrosis of the pancreas garnered from the literature and from the autopsy files of the Babies Hospital [1] . Since that time our understanding of the disease has progressed steadily, and contributions to it have been made by many workers in many lands. My present objective is to review the growth in our knowledge and to present the current problems.
The 1938 series of post-mortem cases fell into three groups corresponding to the age at death, with dissimilar clinical stories but essentially identical changes in the pancreas. 5 of the infants of the 1938 series died of congenital small intestinal obstruction, variously diagnosed as meconium ileus, volvulus, obstruction due to a peritoneal band and atresia of the small intestine. The second group was composed of 19 infants who appeared sound at birth, gained poorly in early infancy in spite of normal food intake and died of bronchopneumonia before the sixth month. The third group was composed of 25 children aged 6 months to 14i years who had gained poorly during infancy, later presented a clinical picture often leading to the diagnosis of coeliac disease, and still later had developed bronchitis, bronchiectasis and sinusitis. Later, when clinical diagnosis was possible and therapy began to have an effect on the life span, the groups were redefined as follows: Group I, patients with congenital intestinal obstruction; Group II, the early group patients with onset of chronic cough before the 6th month; and Group III, the late group of patients with onset of chronic cough after 6 months of age.
The pathological changes are chiefly in the pancreas, lungs and, in Group I, in the intestine. The changes in the pancreas may be interpreted as the result of an abnormality in the secretion, which causes it to be precipitated as eosinophilic material in the lumina of acini and ducts in increasing amounts. Main ducts are often patent but are sometimes plugged with secretion or are atretic. There is a progressive change in age, with increase in the contents of the lumina, and gradual atrophy of acini and replacement by fibrous tissue and sometimes by fat. The islands of Langerhans are unaffected.
The lung changes also vary with the age of the patient. In infants dying of intestinal obstruction in the neonatal period the lungs and bronchi are normal.
JAN.-PAEDIAT. 1 In the young infants dying with bronchopneumonia there is an acute purulent bronchitis with Staphylococcus aureus as the infecting organism. Bronchogenic abscesses, sometimes perforating to produce pyopneumothorax, may be present and a lobe, or a large portion of one, may become atelectatic because of plugging of a bronchus. In later cases there is diffuse tubular chronic bronchiectasis in the tertiary and smaller.bronchi, with thick peribronchial infiltration. The larger bronchi and trachea may be filled with pus in the terminal phase. Cases which have not received dietary and vitamin-A therapy show the squamous metaplasia of the bronchial epithelium resulting from vitamin-A deficiency. In some of the older patients the staphylococcus is accompanied by other organisms, usually of the colon group.
In our own series of congenital intestinal obstruction with fibrocystic disease, now numbering about 14 cases, the infant has usually been surgically explored on the third to sixth day. In the earlier cases of the series the most common surgical diagnosis was volvulus. It is now realized that the cause of the obstruction is the nature of the meconium itself. In the distal portion of the ileum the meconium is hard and grey, resembling dry putty, and cannot pass the ileocecal valve. This material occupies the distal 10-15 cm. of ileum. Proximal to it there is a large loop of ileum distended with dark brown or green sticky meconium and fices. Because of its size and weight this loop often forms a volvulus or becomes gangrenous because of poor circulation. Farber has shown that the meconium from these infants can be softened by application of pancreatic juice and suggests plausibly that the meconium is abnormal for want of pancreatic digestion [2] .
Fatty liver was frequently found in the untreated cases of the early series but has rarely been present in treated cases. Pericholangitis, Laennec's cirrhosis and inspissated secretion in a few bile ducts have occasionally been observed. The gallbladder is small and contains inspissated secretion but no bile in about one-third of the total number of cases including those of Groups II and III.
Fibrocystic disease frequently occurs in more than one sibling of a family. Twenty family trees have been obtained in an effort to determine the hereditary pattern [3] .
Calculations based on Hogben's formula give a mean incidence of 250% of siblings with the disease in affected families. Although this frequency suggests a recessive trait, the-pattern of family incidence is against this, since there are more than the expected number of families in which the majority of siblings are affected. A geneticist who was consulted on this point remarked that the pattern suggested either that the concurrence of two factors was required for the expression of the disease, or that the disease was carried as a dominant trait but could be suppressed by a second factor. This irregularity of incidence has practical application in giving advice to parents of two or more children with the disease. The disease may occur in one or both of twins. Sex distribution is about equal. I know of three instances of first cousins having the disease out of about 300 cases of which I have some knowledge. There is suggestive evidence of the occurrence of cases in some of the previous generations. In several instances the majority of siblings of a large family in a previous generation are said to have died of bronchopneumonia in early infancy, and in one family with two infants with meconium ileus there was a maternal aunt who died of intestinal obstruction in the neonatal period. It seems probable that in another decade or so there will be evidence as to the transmission of the disease to offspring of known cases.
The diagnosis of the disease may be suspected from the clinical picture but must be confirmed by laboratory means. Since early diagnosis greatly improves the prognosis we frequently consider the possibility of this disease in differential diagnosis of infants with malnutrition.
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The clinical picture on hospital admission is quite variable. In Group I the meconium lleus may be recognized at operation by a surgeon who is familiar with it.
However, the obstruction is often attributed to the volvulus or to congenital bands found about the ileum, and the inspissated meconium is therefore left and continues to block the lumen.
One of the surgeons of the Babies Hospital, Dr. Robert Hiatt, has devised a procedure which has been successful in 5 of 8 cases [4] . This consists of making an incision at the junction of the dilated loop of ileum and the distal portion containing the inspissated meconium. After clamping the proximal loop the distal loop is dilated with saline to separate the firm and moulded meconium from the mucosa, after which the meconium is milked out. The procedure is repeated until the saline passes freely into the colon. The distal loop is then clamped and the procedure repeated on the proximal loop. The incision is then closed. In one case it was necessary to remove the loop forming the volvulus. A diluted solution of pancreatin is given by gastric tube. When feedings are begun they consist of protein milk, glucose and casein hydrolysate.
The cases of Croup II with early onset form the majority of all cwes of fibrocystic disease. The mast characteristic picture is that of an infant aged 2-6 months who appeared normal at birth but is slow in regaining his birth-weight and continues to gain slowly in spite of an excel-lent appetite and adequate feeding. After some weeks of poor gain he develops a respiratory infection and is admitted with a diagnosis of bronchopneumonia. Sometimes he is admitted as a feeding problem and the respiratory infection appears later. The stools may appear normal except for a slight increase in number. There are also some patients of this group who have diarrhoea in the early months. Differential diagnosis in this age-period includes poor feeding, early cceliac disease, pertussis, lipoid pneumonia, epidemic diarrhoea of the newborn, asthma, early megacolon, and atelectasis due to foreign body aspiration.
The cases of Group III, with onset after six months, may give a history of having had mild diarrheea in the neonatal period but rarely have had watery stools after the sixth month. Stools are increased in bulk and often in number and after the first few months are foul with a distinctive odour which one mother described as resembling stale marigolds. The experienced nurse can often make the diagnosis by olfactory sense alone. There may have been a cold or bronchitis in the early months which responded to penicillin. In some cases the physical contours and foul stools have led to the diagnosis of coeliac disease in the second year. Colds are frequent and prolonged but the cough may not be constantly present for some years. Sooner or later the respiratory symptoms dominate the picture and the child has a barrel chest, cyanosis, clubbed fingers, and a paroxysmal cough. In the differential diagnosis of this group the conditions to be considered include coeliac disease, asthma, chronic bronchiectasis, and tuberculosis. So far the most reliable laboratory means of confirmirlg the diagnosis is the assay of duodenal juice for pancreatic enzymes [5] . Preliminary observations on a series! of normal infants and children have shown that trypsin and lipase are present from birth, whereas amylase is not found for the first two or three months of life, and there is normally a wide variation in its concentration during the age-period of 3-6 months. Amylase is usually low or absent in older infants and children with coeliac disease. The absence of amylase cannot therefore be used as a means of diagnosis of fibrocystic disease. In our studies the viscosimetric method was used for the assay of trypsin and amylase and the WillstAdter method for lipase. Although both lipase and trypsin are present throughout infancy, in our hands the method for the determination of trypsin is more sensitive and gives better checks than that for lipase, and we have therefore used the trypsin concentration of the duodenal juice as the means of determiningz ancreatic deficiency. In extreme marasmus from any cause and in dehydration the trypsin concentration may be reduced and the findings equivocal, and the test must be repeated after the clinical condition of the infant has improved. In the great majority of cases of fibrocystic disease the trypsin concentration is under 10 viscosimetric units per c.c. while the highest figure obtained has been 40 units. Normal infants usually have a trypsin concentration of over 200 units per c.c., while in marasmic infants the figure often lies between 40 and 100 units. The viscosimetric determination of the trypsin is a laborious procedure. Because of our policy of suspecting the presence of fibrocystic disease in an attempt to pick up early cases, we have found it advisable to apply a screening test in order to reduce the number of enzyme determinations to the capacity of the laboratory. Two such screening tests have been used. The first is the microscopic examination of faeces for fat [6] . All infants with fibrocystic disease have steatorrhcea when fed whole milk without pancreatin. When microscopic examination of fieces obtained under these conditions demonstrates no fat droplets the diagnosis may be discarded. We have begun to use a second screening test, developed by Shwachman in Boston Children's Hospital which appears.to be satisfactory in the younger age-group [7] . This is the use of X-ray film, with the gelatin scraped from one side. The film is cut to the size of a Petri dish and placed gelatin side up. Pancreatin is withheld from the patient for two days before the feces are obtained. About 1 gramme of feces is diluted with water at 1: 5 and 1: 10 and a drop of each dilution placed on the film with a control drop of water. The dish is covered and left in an incubator at 370 for one hour. In most normal infants the test will show digestion of the gelatin but in cases of fibrocystic disease and in a few older normal children there will be no digestion. It has been found that a solution containing approximately 0-2 viscosimetric units of trypsin will give a positive test.
Other features of the disease have been explored for their value as diagnostic procedures. The vitamin-A absorption curves are affected by steatorrhcea from whatever cause and a flat curve is not specific for pancreatic deficiency. The chemical analysis of faces for nitrogen is reliable but tedious, while analysis for fat is reliable only when an excess of neutral fat is recovered. An amino-acid absorption curve based on the determination of serum amino acids after ingestion of casein or gelatin is said to be a reliable means of diagnosis but also requires special techniques [8] . TREATMENT There are two main methods of treatment: dietary therapy which attempts to compensate for the defective digestion and chemotherapy directed at the respiratory infection [9, 10] .
The plan of dietary therapy is based on accumulated information in the literature of physiology with regard to the effect of pancreatectomy in animals and on a number of balance studies on patients with fibrocystic disease. It has been found that on a mixed normal diet these patients will excrete about half of the fed protein, half the fed fat, and about 15 % of the fed carbohydrate [11, 12] . In most studies the nitrogen retained from the food is barely adequate to meet the estimated needs, and it appears probable that this is the factor limiting growth in these children.
Theoretically it would seem rational to provide nitrogen as amino acids, but most children of spirit will resist ingestion of the amount of amino acids necessary to supply their total protein requirements. Small amounts may be successfully administered. A positive balance and good growth have been obtained on a daily intake of 6-8 grammes of protein per kilogram of body-weight, of which casein hydrolysate forms 1-1-5 grammes.
Fat is poorly absorbed and also poorly tolerated. As a source of calories carbohydrate can be substituted. A limited amount of fat should be given, with 4 28 Section of Piediatrics care to provide ample amounts of all known and probable fat-soluble essential substances. For this reason the diet should include one or two eggs a day, and a fish-liver oil. Skimmed milk is given and fried foods are forbidden. We have evidence that some fat is absorbed, and that a low dietary fat leads to a larger proportion of fat being absorbed. Vitamin A is fairly well absorbed when a low fat diet with pancreatin is given, and we have assumed that the same may be true of other fat-soluble essential substances. Sugars and polysaccharides do not require pancreatic digestion, and balance studies suggest that some starch may be utilized without the action of pancreatic juice. The carbohydrate intake should therefore be high, since it is the chief source of calories. It is provided as fruits, vegetables, sugars and moderate amounts of cereal foods.
Because of hunger and their digestive handicap, we give frequent feedings to the infants and encourage between-meal snacks in older children.
Supplements include a fish-liver oil concentrate sufficient to provide 30,000 units of vitamin A daily. Vitamin-B complex is given orally and is especially necessary in the younger infants with diarrhoea. Pancreatin is provided at levels of 1-2 grammes per meal. It is of definite benefit in marasmic infants and has some effect, as judged by balance studies, in older children who are doing well.
In practice it is the young infants who respond most dramatically to dietary therapy alone. The special digestive difficulty of these infants is shown by failure to regain the birth-weight for several weeks and by their failure to gain normally on less than 150-200 calories per Kg. Hypoproteinamia and evidence of vitamins A and K deficiency are also encountered more frequently in the younger age-group. Three years ago a'formula now known as Mead-Johnson No. 235 was devised by us for infants who had survived operation for meconium ileus [4, 13] . The mixture is composed of protein milk 50%, casein hydrolysate 50%, banana powder 25 %, glucose 20%. It is based on the observation that the use of a formula composed chiefly of amino acids and glucose led to a high post-prandial rise of these substances in the blood followed by a prompt fall in blood levels and loss in the urine. Feeding with protein milk and cereal led to a large fmcal loss. It seemed reasonable that a judicious mixture of these substances would solve the problem, and this has in fact worked very well.
It has also seemed advisable to commence feeding solids in the form of pureed fruits, bananas and meats at an early age, about 3 months, as a means of providing necessary minerals and calories. Cereal has been withheld until about 1 year of age.
Skim milk with added sugar is substituted for Number 235 in the latter half of the first year. By the third year the diet approaches a normal one with several notable exceptions. Skim milk and double portions of protein foods and an abundance of sugar and fruit are given, cereal foods are limited to one serving per meal, and all foods of high fat content such as cream, ice cream and fried foods are prohibited. For the sake of morale, ice cream is allowed once a week.
RESULTS
Several weight curves and photographs of patients were then shown as examples of the success of this regime. These included a group of patients successfully treated for meconium ileus, the oldest now 3 years of age; and several children in whom diagnosis was made early because of the presence of the disease in a sibling.
The success of therapy of the respiratory infection associated with fibrocystic disease is dependent on two factors. (1) the phase of the infection at which therapy is instituted, and (2) the sensitivity of the infective bacteria to the chemotherapeutic agents available. Experience has shown that if the cough has been present for only a few weeks and the infecting agent is a staphylococcus sensitive to penicillin, the infection may be so well controlled that all clinical and roentgen signs of it disappear. A mild intection with an organism which is insensitive to available agents frequently progresses to a fatal termination in a few weeks or months. A chronic bronchitis, with roentgen findings of thickened bronchovascular markings and even with diffuse "'snow-flake" lesions through the lung parenchyma but with a sensitive organism, m4y give a dramatic clinical response to therapy.
Damage to the bronchi, especially diffuse tubular bronchiectasis, may remain, with persistent thickening of bronchial shadows as seen by X-ray. Patients who have responded to chemotherapy but retain damage to the bronchi have increased in number since penicillin was first available to us four years ago and have presented new problems of management. In spite of good nutrition and activity these children have a cough, usually on rising, and a tendency to recurrent infection. Those with most severe changes sometimes develop bronchitis due to Ps. pyocyaneus or other Gram-negative bacilli, a complication rarely seen before the days of penicillin. Though this infection may respond to streptomycin the prognosis is poor, since this type of infection is associated with severe anid irreversible anatomical damage. Several of these children have survived their pulmonary infection only to die in right heart failure, another clinical picture not seen before penicillin was available.
We have developed certain policies in regard to the use-of the newer drugs on a more or less empirical basis. These policies have altered and are still changing with experience. The following is a statement of our present routine rather than a perfect plan of therapy. The actual procedure is as follows: When a child is admitted to the hospital with the clinical picture and tentative diagnosis of fibrocystic disease, the preliminary work-up is brief and both dietary and penicillin therapy are started on the day of admission. The work-up considered necessary prior to beginning therapy consists of obtaining cultures of the nose and throat, and if possible of sputum, and an X-ray of chest. The cultures are sent to the laboratory for sensitivity tests to penicillin and other drugs but therapy is not delayed for these reports. Other data to be obtained before the end of the second day in hospital are (1) serum protein, (2) serum vitamin A and carotene, (3) blood-count, (4) urine examination, (5) microscopic examination of faeces for fat. After clinical improvement the diagnosis is confirmed by assay of the duodenal juice for trypsin.
Because the usual infecting organism is a staphylococcus which is sensitive to penicillin, this drug is used first. Large doses are used, since experience has shown that the effective doses are similar to those required for subacute bacterial endocarditis, and since staphylococci tend to develop resistance to penicillin. Oral penicillin or penicillin in wax given only twice a day are forbidden these patients. At present for the first course, the usual dose is 100,000 units by intramuscular injection and the same by aerosol every three hours for seven to fourteen days. Penicillin by inhalation is a valuable therapeutic weapon in these cases and is much more effective here than in the chronic bronchiectasis of adults where the flora is usually varied. It is considered as a topical application of penicillin, with the purpose of applying the maximum amount of the drug to the site where, as shown at postmortem examinations, the greatest concentration of bacteria exists. Most children of 18 months or over can be taught to co-operate in the administration of aerosol by mask, but the younger patients and the extremely ill are given aerosol into an oxygen tent. The frequency of the treatments is increased in these patients to 100,000 units hourly.
Because of the tendency of the staphylococcus to develop resistance to penicillin we have been avidly grasping new drugs as they become available. So far we have used in the same manner the following antibacterial drugs: Streptomycin, Bacitracin, Sulphathiazole, Polymyxin B and Aureomycin. Our experience with some of these 30 is limited and I can make only a few useful statements about them. Streptomycin is highly effective against Gram-negative organisms and can be used by aerostl in surprisingly large doses, partly because it dif3fuses poorly and partly because it is largely coughed up with the sputum. Bacitracin is so far the only agent effective in cases with penicillin resistance but it has two drawbacks, probably due to impurities. Some batches are highly irritating to the nasal mucous membranes and some batches produce oliguria and an elevated serum non-protein nitrogen. Other batches are without these defects and it is probable that this agent will be of greater usefulness before long.
The following cases illustrate some of these points. Both were of the older group, Group III, and had chronic lung changes when first seen. Marguerite was one of the first patients to receive penicillin aerosol, in July 1944. At that time we were able to obtain only enough for a dose of 5,000 units every three hours for five days. This was administered by aerosol through a catheter to the posterior nasopharynx, since we had not as yet devised the mask technique.
On admission Marguerite was 4 years old, had had intermittent cyanosis for four months, continuous cyanosis for several days and was extremely ill. Her response was dramatic but she relapsed after a week or so, and received several courses of penicillin at low dosage-all that we were able to obtain, however. I now consider it mere good luck that she did not develop resistance to the drug. After three courses of aerosbl over a period of two months, she continued to improve without it, with disappearance of clubbing and reduction of chest cir,vnfeizence by 2 in. She continued to do well until June 1948, when an attack of influenza was -followed by a productive cough and loss of weight. She received another course of penicillin in July and is again doing well at the age of 8 years.
Sidney presents a more gloomy picture. On admission he was not as ill as Marguerite had been, but cultures from his throat and sputum grew a staphylococcus with high resistance to penicillin. His chart illustrates the usual course of these patients and also the rather fumbling manner in which we are still using the newer drugs.
It is apparent that chemotherapy applied early in the course of infection with a sensitive organism may result in control of the infection; the prognosis of patients who have once had a severe chronic infection is still uncertain.
In spite of the advance in our knowledge there remain many unsolved problems. The most pressing of these is the relationship between the respiratory infection and the pancreatic deficiency. There are at present two hypotheses as to the atiology of the respiratory infection. The older of these is the theory that the infection follows deficiency of some nutritional substance required for the normal function of the bronchi, a deficiency resulting from the lack of pancreatic secretion. The other hypothesis is that the bronchial secretion is congenitally abnormal in a manner analogous to the pancreatic secretion. This question has not been definitely settled. The arguments for the congenital theory are based on the constancy with which the infection appears, the acknowledged occasional occurrence of abnormalities of glands other than the pancreas in these cases, and the viscosity of the exudate in the bronchi. The nutritional theory, which I hold, is based on the knowledge that untreated patients with fibrocystic disease are sometimes deficient in certain nutritional factors, such as vitamin A, and that most patients in whom early diagnosis has led to early appropriate dietary therapy have not developed a chronic respiratory infection [13] . Much more investigation is required before we can accurately assess the defects in nutrition of these children, especially with respect to fat-soluble essential substances. The basic question will not be solved until we have evidence that these children are deficient in a specific substance known to be required by the bronchi, or until, on the other hand, a specific abnormality of the bronchial mucus is demonstrated to be congenital.
The evidence for the intestinal theory is sufficiently strong so that the patients should be given dietary therapy based on our present understanding of their needs.
A case is presented of a child of 7j years who was diagnosed and started on dietary therapy at the age of 6 weeks. She has continued free of respiratory infection, has maintained a normal growth curve, and leads an active and normal life, except for moderate dietary restriction. SUMMARY Our knowledge of cystic fibrosis of the pancreas has progressed to a point where a clinical diagnosis can be made early in the disease. Response to a combination of dietary therapy and chemotherapy depends on the sensitivity of the infecting bacteria to available chemotherapeutic agents and on the stage of the pulmonary lesion when therapy is begun. Early diagnosis and therapy lead to an improved prognosis, and may result in freedom from respiratory infection, at least for the span of years over which observation has been possible. The urgent unsolved problem is the discovery of the cause of the respiratory infection. There is strong presumptive evidence that it is due to a specific nutritional deficiency.
